Company Analysis
Sign in

Kala Bio, Inc. (KALA)

Nasdaq: KALA · Pharmaceutical Preparations · Arlington, MA · filing with the SEC since 2009
Full chart Alerts Compare
Grade4.3
◀ Past 2.0● Present 2.7▶ Future 7.2
4 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

61 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Kala Bio, Inc.’s names, not what it holds today.

Patents granted
61
61 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 2 in 2024 and 2 in 2023
Applications published
82
3 of them in 2025
Names they are printed under
4
a former name, a subsidiary
By yearGrantedApplications published
'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals17
Organic fine chemistry1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Kala Pharmaceuticals, Inc. a former name
US, as the owner printed on each patent
53 granted
12 published
Kala Pharmaceuticals, Inc. a former name
named as the applicant on its applications, in US
0 granted
58 published
Combangio, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
12 published
COMBANGIO, INC. a subsidiary
US, as the owner printed on each patent
8 granted
0 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Jan 7, 202512,187,784Processes for making a cellular fibronectin compositionPharmaceuticalsCOMBANGIO, INC.
Jan 7, 202512,186,430Lyophilized mesenchymal stem cell derived secretome and uses thereofPharmaceuticalsCOMBANGIO, INC.
Mar 5, 202411,919,942Methods for treating an ocular condition with cellular fibronectin compositionsPharmaceuticalsCOMBANGIO, INC.
Feb 6, 202411,891,428Cellular fibronectin compositionsPharmaceuticalsCOMBANGIO, INC.
Aug 1, 202311,713,323Crystalline forms of therapeutic compounds and uses thereofPharmaceuticalsKala Pharmaceuticals, Inc.
May 23, 202311,654,160Processes for making and using a mesenchymal stem cell derived secretomePharmaceuticalsCOMBANGIO, INC.
Aug 2, 202211,401,260Biochemical binding of RET9 and VEGFR2 inhibitorsPharmaceuticalsKala Pharmaceuticals, Inc.
Jun 28, 202211,369,611Therapeutic compounds and uses thereofPharmaceuticalsKala Pharmaceuticals, Inc.
Jun 7, 202211,352,343Urea derivatives and uses thereofPharmaceuticalsKala Pharmaceuticals, Inc.
May 3, 202211,318,088Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucusPharmaceuticalsKala Pharmaceuticals, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Jul 10, 20252025/0222035PROCESSES FOR MAKING AND USING A MESENCHYME STEM CELL SECRETOME FOR LIMBAL STEM CELL DEFICIENCY (LSCD) TREATMENTPharmaceuticalsCombangio, Inc.
Jun 19, 20252025/0197477PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITIONPharmaceuticalsCombangio, Inc.
Jun 19, 20252025/0195438LYOPHILIZED MESENCHYMAL STEM CELL DERIVED SECRETOME AND USES THEREOFPharmaceuticalsCombangio, Inc.
Mar 21, 20242024/0091268PREPARATION AND PURIFICATION METHODS FOR MESENCHYMAL STEM CELL DERIVED SECRETOMEPharmaceuticalsCombangio, Inc.
Feb 1, 20242024/0033297PROCESSES FOR MAKING AND USING A MESENCHYMAL STEM CELL DERIVED SECRETOMEPharmaceuticalsCombangio, Inc.
Jan 11, 20242024/0012011METHODS AND ASSAYS FOR SECRETOME ACTIVITY ANALYSISPharmaceuticalsCombangio, Inc.
Apr 13, 20232023/0116686THERAPEUTIC COMPOUNDS AND USES THEREOFPharmaceuticalsKala Pharmaceuticals, Inc.
Jan 5, 20232023/0002476PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITIONPharmaceuticalsCombangio, Inc. · patent 11,891,428 granted from it
Jan 5, 20232023/0000954PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITIONPharmaceuticalsCombangio, Inc. · patent 12,187,784 granted from it
Jul 14, 20222022/0218597COMPOSITIONS AND METHODS UTILIZING POLY(VINYL ALCOHOL) AND/OR OTHER POLYMERS THAT AID PARTICLE TRANSPORT IN MUCUSPharmaceuticalsKala Pharmaceuticals, Inc. · patent 11,878,072 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 6.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton KALA · research, not advice